Ficar parado é entregar protagonismo para quem souber desenhar conteúdo pensando no invisível, no que não se diz, no que se ...
Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback